LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 64 filers reported holding LEAP THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,524,694 | +902.4% | 7,425,570 | +1226.7% | 0.01% | +600.0% |
Q4 2022 | $251,867 | -48.9% | 559,705 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $493,000 | -23.4% | 559,705 | 0.0% | 0.00% | -25.0% |
Q2 2022 | $644,000 | -34.2% | 559,705 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $979,000 | -46.0% | 559,705 | 0.0% | 0.01% | -33.3% |
Q4 2021 | $1,813,000 | -19.2% | 559,705 | 0.0% | 0.01% | -10.0% |
Q3 2021 | $2,244,000 | +144.4% | 559,705 | 0.0% | 0.01% | +150.0% |
Q2 2021 | $918,000 | -13.6% | 559,705 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $1,063,000 | -15.6% | 559,705 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $1,259,000 | +13.6% | 559,705 | 0.0% | 0.01% | +25.0% |
Q3 2020 | $1,108,000 | -45.8% | 559,705 | -42.8% | 0.00% | -55.6% |
Q2 2020 | $2,045,000 | +32.3% | 978,454 | 0.0% | 0.01% | -10.0% |
Q1 2020 | $1,546,000 | +41.1% | 978,454 | 0.0% | 0.01% | +66.7% |
Q4 2019 | $1,096,000 | -4.3% | 978,454 | 0.0% | 0.01% | -25.0% |
Q3 2019 | $1,145,000 | – | 978,454 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 904,600 | $2,035,000 | 1.08% |
SILVERARC CAPITAL MANAGEMENT, LLC | 275,000 | $619,000 | 0.36% |
Perceptive Advisors | 8,476,496 | $19,072,000 | 0.20% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $1,800,000 | 0.16% |
Golden Green, Inc. | 69,580 | $157,000 | 0.15% |
Artal Group S.A. | 3,000,000 | $6,750,000 | 0.14% |
HHLR ADVISORS, LTD. | 3,716,240 | $8,362,000 | 0.07% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,065,259 | $2,397,000 | 0.06% |
Windsor Creek Advisors, LLC | 89,972 | $202,000 | 0.05% |
PERSONAL CFO SOLUTIONS, LLC | 73,165 | $165,000 | 0.04% |